News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Salix Pharmaceuticals, Ltd. Announces 3Q2005 Financial Results Conference Call And Webcast
October 25, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
RALEIGH, N.C.--(BUSINESS WIRE)--Oct. 25, 2005--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will report third quarter ended September 30, 2005 financial results before the market opens on Tuesday, November 8, 2005.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Podcast
Q3 earnings roll on, FDA pushes rare disease, uniQure’s Huntington’s therapy reaches review
November 4, 2026
·
1 min read
·
Jef Akst
Earnings
Pfizer, fresh to China’s obesity market, looks to Viagra model to compete
November 3, 2026
·
3 min read
·
Annalee Armstrong
Psychedelics
Compass to submit psilocybin depression drug for approval imminently after stock wobbles
November 3, 2026
·
2 min read
·
Heather McKenzie
Rare diseases
Neurocrine defends Prader-Willi drug after another patient death
November 3, 2026
·
3 min read
·
Annalee Armstrong